Allan Medina

Allan Medina is a partner in Goodwin’s Complex Litigation & Dispute Resolution and Healthcare practices. He focuses on representing companies, boards, and individuals in the healthcare and life sciences sectors in criminal government enforcement investigations and trials, as well as conducting internal investigations and advising on compliance issues. Allan recently served as the Senior Deputy Chief in the U.S. Department of Justice, Criminal Division, Fraud Section, where he supervised approximately 191 federal prosecutors, data analysts, and support staff across many practice areas, including healthcare fraud, Foreign Corrupt Practices Act, corporate compliance, securities and investment fraud, Crypto fraud, and money laundering. Allan has over 15 years of white collar enforcement, federal jury trial, and corporate enforcement policy experience, as well as broad credibility with the agencies and leaders in the white-collar law enforcement community.

Combining more than a decade of federal prosecutorial experience, leading the most complex and high profile criminal cases in multiple jurisdictions throughout the country, and extensive courtroom expertise, Allan is uniquely positioned to provide insightful and effective representation to clients facing government and regulatory scrutiny. He has first chaired federal trials throughout the country and played a key role in shaping significant corporate enforcement policies. Allan’s experience includes:

• First chairing a federal jury trial against an owner of more than a dozen skilled nursing and assisted living facilities in what was then the largest health care fraud case ever charged by the Department of Justice. Following an eight-week trial in the Southern District of Florida, a federal jury convicted the defendant of 20 counts, including conspiracy, money laundering, kickbacks, obstruction, and federal program bribery. United States v. Philip Esformes, Case No. 16-CR-20549 (S.D.F.L. 2016)*
• First chairing a federal jury trial against a doctor and medical biller who knowingly submitted fraudulent bills for services that they knew had not been provided, namely expensive nerve block injections. Following a four-week trial in the Eastern District of Michigan, the defendants were convicted of conspiracy to commit health care fraud and wire fraud and health care fraud. United States v. Johnny Trotter, et. al. Case. No. 14-CR-20273 (E.D.M.I. 2014)*
• First chairing a federal jury trial against a doctor and five therapists who submitted and caused the submission of more than $63 million in false and fraudulent claims. The defendants worked at Health Care Solutions Network, a now defunct community mental health center and partial hospitalization program in Miami, Florida and Asheville, North Carolina. The fraud centered on claims for mental health services that were not needed nor provided. United States v. Roger Rousseau, et. al. Case No. 13-CR-20505 (S.D.F.L. 2013)*
• Co-counsel in a federal jury trial against a doctor and registered nurse who submitted and cause the submission of false and fraudulent claims for home health care services. Following a three-week trial in the Northern District of Texas, the defendants were convicted of conspiracy and health care fraud. United States v. Joseph Megwa, et. al., Case No. 12-CR-312 (N.D.T.X. 2012)*
• Co-counsel in the prosecution of Alcoa World Alumina LLC, a majority-owned and controlled global alumina sales company of Alcoa Inc. Alcoa World Alumina LLC agreed to plead guilty and pay $223 million in criminal fines and forfeiture for its role in a corrupt long-term alumina supply agreement with an aluminium smelter company located in Bahrain.*
• Participated in the investigation and prosecution of Gerald Green and Patricia Green, Los Angeles-area film executives who were found guilty by a jury in the Central District of California of conspiracy to violate the Foreign Corrupt Practices Act and on money laundering counts. Patricia Green was also found guilty of falsely subscribing U.S. income tax returns.*

* Denotes experience prior to joining Goodwin.

Prior to joining Goodwin, Allan served for the Fraud Section of the Criminal Division of the US Department of Justice for almost 15 years. In his most recent role as Senior Deputy Chief, Allan supervised and managed more than 190 federal prosecutors, data analysts, and support staff across practice areas including healthcare fraud, the Foreign Corrupt Practices Act, corporate compliance, securities and investment fraud, crypto and digital assets fraud, and money laundering.

Previously, Allan served as Chief of the Health Care Fraud Unit, where he was the DOJ Criminal Division’s most senior prosecutor of healthcare cases. He supervised more than 74 prosecutors and data analysts in investigating and prosecuting individuals and companies across the country in complex healthcare fraud matters. As a Fraud Section leader, Allan served as a key liaison to various governmental and regulatory stakeholders including the Office of the Inspector General, US Department of Health and Human Services, the FBI, and state attorneys general. Many of the investigations he supervised also involved close coordination with federal prosecutors, regulators, and law enforcement agencies around the world.

Prior to his leadership roles, Allan served as a trial attorney for the Health Care Fraud Unit. He tried several cases in various federal districts and investigated and prosecuted a variety of matters including healthcare fraud, money laundering, federal program bribery, kickbacks, Anti-Money Laundering compliance and violations of the Bank Secrecy Act.

Previously, Allan was a law clerk at Podhurst Orseck where he represented individuals in significant white collar matters, most often involving health care fraud, money laundering, and bribery schemes. He served as co-counsel in a federal trial involving criminal health care fraud.

For his work in the Health Care Fraud Unit, Allan received the Assistant Attorney General Award for Exceptional Service and the HHS-OIG Inspector General’s Award for Excellence in Fighting Fraud Waste and Abuse. He was named Prosecutor of the Year by the Coalition Against Insurance Fraud, and was recognized by the National Health Care Anti-Fraud Association for leading the 2019 Investigation of the Year.

Allan regularly delivers keynote addresses and serves as a panelist about criminal enforcement, healthcare fraud, and compliance at national conferences and events focused on white collar defense and healthcare fraud, including those sponsored by the ABA, the American Health Law Association (AHLA), and the International Performance Management Institute (IPMI).

• Speaker, “Annual Ethics Seminar,” National Health Care Anti-Fraud Association Annual Training Conference, November 22, 2024
• Speaker, “Chief Compliance Officer Roundtable,” 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, October 29, 2024
• Speaker, “Anatomy of a Corruption Investigation for Pharmaceutical and Medical Device Companies,” Seton Hall University School of Law's European Healthcare Compliance Certificate Program, October 21, 2024
• Speaker, “Medicare and Medicaid Managed Care Fraud and Enforcement,” American Bar Association (ABA) Institute on Health Care Fraud, May 2024
• Interviewed, “Forecasting the DOJ’s AI enforcement priorities,” Compliance Week, May 7, 2024
• Co-Author, “Decoding DOJ's New 'Justice AI' Initiative,” Law.com, March 11, 2024
• Speaker, “Health Care Fraud Enforcement, Defense, and Corporate Compliance – Where are we today?,” ABA National Institute on White Collar Crime, March 6, 2024
• Co-Author, “Foreign Extortion Prevention Act (FEPA) Expands US Authority to Reach Foreign Bribery,” Goodwin Client Alert, February 2, 2024